Timothy C. Gupton

Founded in 2001, Research Triangle Ventures LLC is a seed- and early-stage venture capital fund based in Raleigh, North Carolina.

Enhance Biotech, Inc. engages in the acquisition, development and commercialization of drugs for lifestyle disorders. The company was founded on June 7, 1999 and is headquartered in New York, NY.

Cropsolution, Inc. engages in the discovery and development of agrochemicals. It focuses on the discovery of molecular compounds for use as herbicides, pesticides and fungicide. The firm uses evolutionary chemistry for the discovery of novel molecular compounds that have utility as agrochemical. The company was founded in January 2001 by Eric R. Ward, Michelle D. Hunt and Scott J. Uknes and is headquartered in Cary, NC.

KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY.

Gentris Corp. provides applied clinical phamacogenomic services. The company was founded on March 2001 and is headquartered in Morrisville, NC.

Hughes Pittman & Gupton LLP is an independent CPA firm that has been serving the needs of local, multistate, and international businesses for over 30 years. The private company is based in Raleigh, NC and is committed to a business and personal model based on core values such as respect, excellence, and client satisfaction. The firm offers specialized teams to address the unique tax, audit, accounting, and advisory needs of owner-managed and investor-owned clients across a wide range of industries, including cleantech, construction, healthcare, and technology.

CoLucid Pharmaceuticals, Inc. engaged in the development of therapeutics for neurological disorders. Its products included Lasmiditan, a neurally acting anti-migraine agent that is designed to delivered efficacy in migraine without the vasoconstrictor activity associated with previous generations of migraine therapies and a Conjugated Stigmines platform that has generated a series of preclinical candidates for the chronic pain, Alzheimer's disease and psychiatric disorders. The company was founded by James F. White and Arthur M. Pappas in 2005 and was headquartered in Cambridge, MA.